Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Forecasted Growth Rate and Market Size of the Headache Disorders Market?
The market size for headache disorders has seen robust growth in the past few years. It’s anticipated to increase from $4.64 billion in 2024 to $4.93 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.2%. Factors contributing to the growth during the historic period include the scarcity of treatment alternatives, heightened awareness, an increase in headache incidents, improvements in healthcare infrastructure, lifestyle changes, and elevated stress levels.
In the coming years, the market size for headache disorders is anticipated to witness robust expansion. It is projected to reach “$6.83 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.5%.” This expected surge during the forecast period can be credited to factors such as the advent of digital health solutions, customized medicine strategies, the rise in research and development investments, a globally aging population, and growth in neuroinflammation research. The forecast period is also likely to be characterized by significant trends like technological advancements in treatment protocols, a heightened emphasis on preventive therapies, a wide-ranging pipeline of innovative therapies, and an upswing in non-pharmacological approach utilization.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9452&type=smp
Which Factor Is Shaping The Future Of The Headache Disorders Market?
The growing commonness of migraines is predicted to drive the expansion of the headache disorders market. Migraine is a type of headache identified by recurrent episodes of moderate to severe pulsating and throbbing pain on one side of the head. Neurological disorders resulting from headache disorders can generate debilitating throbbing pain, fatigue, and nausea, potentially leading to migraines. For instance, the Journal of Headache and Pain, a UK-based Peer-reviewed journal, reported in April 2022 that an active headache disorder was identified in 52.0% of the analysed populations, with a prevalence of 44.4% in males and 57.8% in females. Migraines impacted 14.0% of the population (8.6% in males and 17.0% in females), while tension-type headache (TTH) was prevalent in 26.0% of the population, affecting 23.4% of males and 27.1% of females. Hence, the escalating prevalence of migraines is boosting the demand for the headache disorders market.
What Is The Segment-Wise Breakdown Of The Headache Disorders Market?
The headache disorders market covered in this report is segmented –
1) By Type: Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types
2) By Treatment: Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy
3) By Diagnosis: Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Migraine: Chronic Migraine, Episodic Migraine, Migraine With Aura, Migraine Without Aura
2) By Tension-Type Headache: Episodic Tension-Type Headache, Chronic Tension-Type Headache
3) By Cluster Headache: Chronic Cluster Headache, Episodic Cluster Headache
4) By Medication-Overuse Headache: Analgesic-Overuse Headache, Caffeine-Withdrawal Headache
5) By Other Types: Sinus Headache, Hormonal Headache, Thunderclap Headache, Other Primary And Secondary Headaches
How Are Key Trends Driving Expansion In The Headache Disorders Industry?
In the headache disorder market, major businesses are focusing their efforts on the creation of novel products such as migraine tablets. These tablets are medicines with the goal of relieving or preventing migraine symptoms like pain and inflammation. This is achieved through targeting the specific pathways that these symptoms follow. For example, Akums Drugs & Pharmaceuticals, a pharmaceutical manufacturer from India, launched a generic form called the Lasmiditan Tablet in January 2024. The target of the tablet is the acute relief of migraines and it’s a version of Eli Lilly’s REYVOW. The tablet, greenlighted by both the USFDA and the DCGI, works to soothe migraine symptoms by binding to the 5-HT1F serotonin receptor. This interaction disrupts pain signals and decreases inflammation in the nerve. The recommended dosage is from 50 mg to 100 mg per day, but not to exceed one dose within 24 hours.
Which Companies Hold The Largest Market Share In The Headache Disorders Sector?
Major companies operating in the headache disorders market include Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., Amgen Inc., Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eisai Co. Ltd., Impax Laboratories LLC, Lannett Company Inc., Lupin Pharmaceuticals Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/headache-disorders-global-market-report
How Does Regional Performance Compare Across The Headache Disorders Industry?
North America was the largest region in the headache disorders market in 2024. The regions covered in the headache disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9452&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model